Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Clinical trial NCT06369155 · RECRUITING
Trial details
- NCT number
- NCT06369155
- Sponsor
- Joyce Liu, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2027-01-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.